SREBF1 and cancer: However, due to the dual-luciferase reporter assay was conducted in HepG2 cells which are cancer cells and might not really reflect the physiological activity of PLZF on SREBP-1c, therefore, a “normal” hepatocyte cell line, such as AML12 cell, maybe used to confirm this data in future.